Article Type
Article
Changed
Thu, 01/10/2019 - 13:48
Display Headline
Nail-Patella Syndrome: Clinical Clues for Making the Diagnosis
Author(s)
Alexandra Price, MD
Jessica Cervantes, BS
Scott Lindsey, MD
Divya Aickara, MS
Shasa Hu, MD

Nail-patella syndrome (NPS), also known as hereditary osteo-onychodysplasia syndrome, is a rare autosomal-dominant disorder with an estimated incidence of 1 per 50,000 individuals in the United States. Nail-patella syndrome presents due to a heterozygous loss-of-function mutation in the LIM homeobox transcription factor 1 beta gene, LMX1B, on chromosome 9q34.1 LMX1B gene mutations are fully penetrant, but there is variable expressivity, even within families.2

Case Report

A 69-year-old man presented to the dermatology clinic for a routine skin cancer screening. The patient’s history was remarkable for dystrophic fingernails and toenails since birth. In his 20s he developed progressively worsening instability of the left knee and chronic back pain due to scoliosis, lumbar lordosis, and spinal disc herniation. Since then, he underwent knee surgery and 7 back surgeries for rheumatologic disease. His medical history also was remarkable for osteoporosis, hypertension, and glaucoma. Family history was notable for similar findings in the patient’s sister; mother; and maternal aunt, uncle, and grandmother, all with varying disease severity.

Physical examination was remarkable for bilateral fingernail hypoplasia that was most prominent on the thumb, with improvement in each nail on progression toward the fifth digit (Figure 1A). Triangular fingernail lunulae, longitudinal ridging, and nail splitting were present (Figure 1A and 1B). Hypoplastic crumbly toenails also were appreciated (Figure 1C). Skin creases over the distal interphalangeal joints of the fingers and toes were conspicuously absent. Limited range of motion was noted in multiple joints, with profound limitation of bilateral elbow extension. Review of prior imaging reports revealed bilateral iliac horns as well as left patellar absence and right patellar hypoplasia (Figure 2). Urinalysis was remarkable for proteinuria and microscopic hematuria. Given the constellation of examination findings and positive family history, a diagnosis of NPS was made.

Figure 1. Nail-patella syndrome characterized by thumbnail hypoplasia (A) as well as triangular lunulae and longitudinal ridging with nail splitting (B). Hypoplastic crumbly toenails were appreciated (C).

Figure 2. Lateral radiographs of the knee joints demonstrated right patellar hypoplasia (A) and left patellar absence (B). A radiograph of the pelvis revealed bilateral triangular osseous excrescences from the posterior ilia, known as iliac horns (arrow)(C). Metallic orthopedic hardware from multiple spinal surgeries performed on the patient also can be appreciated, presumably long-term sequelae of the patient’s condition.

Comment

Nail-patella syndrome is characterized by variable dermatologic, neurologic, nephrogenic, ophthalmologic, and orthopedic clinical manifestations.3 Almost all patients with NPS have bilateral and symmetric nail changes, including absent or hypoplastic nails with ridging, splitting, or discoloration and triangular-shaped lunulae.1,4 Nail findings are the most consistent findings of NPS, as they are present in more than 98% of patients.5 The thumb often is the most severely affected nail, with improvement appreciated on progression toward the fifth digit, as seen in our patient (Figure 1A).5 Each individual nail usually is more severely affected on its ulnar side. When toenails are involved, the abnormalities tend to be less severe, and the little toenail is most commonly affected. Distal digital changes also are observed in almost all patients. Loss of dorsal creases in the skin overlying the distal interphalangeal joints can be considered as a diagnostic clue.3,4

There are a variety of orthopedic manifestations of NPS. Hypoplastic or absent patellae leading to recurrent subluxations or dislocations is a common finding.4 Bilateral symmetric bone formations (horns) arising from the iliac crest are pathognomonic but only found on radiography 70% of the time.6 Occasionally these protuberances can be palpated on physical examination,5 though this finding was not appreciated in our patient. Dysplasia of the elbows may result in limited elbow extension and limited pronation and supination. Early degenerative arthritis, lumbar lordosis, and scoliosis also are not uncommon. In addition, skeletal integrity is compromised, leading to early osteoporosis and increased risk for fractures.5

Nephropathy develops in approximately 30% to 40% of patients and is a major determinant of mortality in these patients.2 Mutations in the LMX1B gene lead to abnormal development of podocytes and reduction in collagen in the glomerular basement membrane. The first sign of renal involvement usually is proteinuria, with or without microscopic hematuria. As in our patient, many patients develop hypertension. Patients may progress to develop nephrotic syndrome and end-stage renal failure (5%–10%).7 Death from NPS-related nephropathy has occurred, even in childhood.4,5

Primary open-angle glaucoma has been recognized as a feature of NPS.8 It is the most frequent ocular abnormality observed, followed by ocular hypertension and Lester sign of the iris.3,5 These conditions also are more common in younger patients with NPS than in the general population.5 Important neurologic findings include epilepsy, peripheral neuropathy, attention deficit disorder, major depressive disorder, and vasomotor problems.9

Our case highlights the importance of recognizing this rare condition to provide a multidisciplinary approach to care that addresses all aspects of LMX1B-associated disease in affected individuals. Nail findings may be the first clue to the need for additional screenings in these patients. Nail-patella syndrome patients should undergo thorough ophthalmologic examinations every 2 years, including measurement of intraocular pressure, examination of the optic disc, and assessment of visual fields. Given the variability in severity of joint problems and the unpredictable anatomy of the joints, magnetic resonance imaging of the joints is recommended prior to orthopedic intervention. Most importantly, physicians should recognize this genodermatosis to implement periodic screenings for renal disease, as up to 40% of NPS patients develop kidney failure. Annual blood pressure measurements, urinalysis, and measurement of the protein to creatinine ratio in the urine are recommended. For patients with end-stage renal failure, renal transplantation results in cure of nephropathy and may even result in nail regrowth.10 Further, this case is notable in that it describes a patient with NPS who is older than most other individuals presenting with the condition, thereby revealing novel information about NPS in its more advanced stages.

References
  1. Harita Y, Kitanaka S, Isojima T, et al. Spectrum of LMX1B mutations: from nail-patella syndrome to isolated nephropathy [published online July 23, 2016]. Pediatr Nephrol. doi:10.1007/s00467-016-3462-x.
  2. Ghoumid J, Petit F, Holder-Espinasse M, et al. Nail-patella syndrome: clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity [published online April 22, 2015]. Eur J Hum Genet. 2016;24:44-50.
  3. Tong SY, Luk HM, Tong TM, et al. The nail points to the diagnosis. Fong disease or hereditary osteo-onychodysplasia. Hong Kong Med J. 2015;21:573.e3-573.e5.
  4. Figueroa-Silva O, Vicente A, Agudo A, et al. Nail-patella syndrome: report of 11 pediatric cases. J Eur Acad Dermatol Venereol. 2016;30:1614-1617.
  5. Sweeney E, Fryer A, Mountford R, et al. Nail patella syndrome: a review of the phenotype aided by developmental biology. J Med Genet. 2003;40:153-162.
  6. Tigchelaar S, Lenting A, Bongers EM, et al. Nail patella syndrome: knee symptoms and surgical outcomes. a questionnaire-based survey [published online November 17, 2015]. Orthop Traumatol Surg Res. 2015;101:959-962.
  7. Lemley KV. Kidney disease in nail-patella syndrome [published online June 6, 2008]. Pediatr Nephrol. 2009;24:2345-2354.
  8. Sweeney E, Hoover-Fong JE, McIntosh I. Nail-patella syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews. Seattle, WA: University of Washington, Seattle; 2003. https://www.ncbi.nlm.nih.gov/books/NBK1132/. Updated November 13, 2014. Accessed January 30, 2018.
  9. Lopez-Arvizu C, Sparrow EP, Strube MJ, et al. Increased symptoms of attention deficit hyperactivity disorder and major depressive disorder symptoms in nail-patella syndrome: potential association with LMX1B loss-of-function [published online November 2, 2010]. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:59-66.
  10. Chan PC, Chan KW, Cheng IK, et al. Living-related renal transplantation in a patient with nail-patella syndrome. Nephron. 1988;50:164-166.
Article PDF
CT101002126.PDF
Author and Disclosure Information

Drs. Price, Lindsey, and Hu and Ms. Cervantes are from the Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Florida. Ms. Aickara is from Florida State University College of Medicine, Tallahassee.

The authors report no conflict of interest.

Correspondence: Jessica Cervantes, BS (J.Cervantes1@umiami.edu).

Issue
Cutis - 101(2)
Publications
Cutis
MDedge Dermatology
Topics
Hair & Nails
Page Number
126-129
Sections
Case Reports
Author(s)
Alexandra Price, MD
Jessica Cervantes, BS
Scott Lindsey, MD
Divya Aickara, MS
Shasa Hu, MD
Author(s)
Alexandra Price, MD
Jessica Cervantes, BS
Scott Lindsey, MD
Divya Aickara, MS
Shasa Hu, MD
Author and Disclosure Information

Drs. Price, Lindsey, and Hu and Ms. Cervantes are from the Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Florida. Ms. Aickara is from Florida State University College of Medicine, Tallahassee.

The authors report no conflict of interest.

Correspondence: Jessica Cervantes, BS (J.Cervantes1@umiami.edu).

Author and Disclosure Information

Drs. Price, Lindsey, and Hu and Ms. Cervantes are from the Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Florida. Ms. Aickara is from Florida State University College of Medicine, Tallahassee.

The authors report no conflict of interest.

Correspondence: Jessica Cervantes, BS (J.Cervantes1@umiami.edu).

Article PDF
CT101002126.PDF
Article PDF
CT101002126.PDF

Nail-patella syndrome (NPS), also known as hereditary osteo-onychodysplasia syndrome, is a rare autosomal-dominant disorder with an estimated incidence of 1 per 50,000 individuals in the United States. Nail-patella syndrome presents due to a heterozygous loss-of-function mutation in the LIM homeobox transcription factor 1 beta gene, LMX1B, on chromosome 9q34.1 LMX1B gene mutations are fully penetrant, but there is variable expressivity, even within families.2

Case Report

A 69-year-old man presented to the dermatology clinic for a routine skin cancer screening. The patient’s history was remarkable for dystrophic fingernails and toenails since birth. In his 20s he developed progressively worsening instability of the left knee and chronic back pain due to scoliosis, lumbar lordosis, and spinal disc herniation. Since then, he underwent knee surgery and 7 back surgeries for rheumatologic disease. His medical history also was remarkable for osteoporosis, hypertension, and glaucoma. Family history was notable for similar findings in the patient’s sister; mother; and maternal aunt, uncle, and grandmother, all with varying disease severity.

Physical examination was remarkable for bilateral fingernail hypoplasia that was most prominent on the thumb, with improvement in each nail on progression toward the fifth digit (Figure 1A). Triangular fingernail lunulae, longitudinal ridging, and nail splitting were present (Figure 1A and 1B). Hypoplastic crumbly toenails also were appreciated (Figure 1C). Skin creases over the distal interphalangeal joints of the fingers and toes were conspicuously absent. Limited range of motion was noted in multiple joints, with profound limitation of bilateral elbow extension. Review of prior imaging reports revealed bilateral iliac horns as well as left patellar absence and right patellar hypoplasia (Figure 2). Urinalysis was remarkable for proteinuria and microscopic hematuria. Given the constellation of examination findings and positive family history, a diagnosis of NPS was made.

Figure 1. Nail-patella syndrome characterized by thumbnail hypoplasia (A) as well as triangular lunulae and longitudinal ridging with nail splitting (B). Hypoplastic crumbly toenails were appreciated (C).

Figure 2. Lateral radiographs of the knee joints demonstrated right patellar hypoplasia (A) and left patellar absence (B). A radiograph of the pelvis revealed bilateral triangular osseous excrescences from the posterior ilia, known as iliac horns (arrow)(C). Metallic orthopedic hardware from multiple spinal surgeries performed on the patient also can be appreciated, presumably long-term sequelae of the patient’s condition.

Comment

Nail-patella syndrome is characterized by variable dermatologic, neurologic, nephrogenic, ophthalmologic, and orthopedic clinical manifestations.3 Almost all patients with NPS have bilateral and symmetric nail changes, including absent or hypoplastic nails with ridging, splitting, or discoloration and triangular-shaped lunulae.1,4 Nail findings are the most consistent findings of NPS, as they are present in more than 98% of patients.5 The thumb often is the most severely affected nail, with improvement appreciated on progression toward the fifth digit, as seen in our patient (Figure 1A).5 Each individual nail usually is more severely affected on its ulnar side. When toenails are involved, the abnormalities tend to be less severe, and the little toenail is most commonly affected. Distal digital changes also are observed in almost all patients. Loss of dorsal creases in the skin overlying the distal interphalangeal joints can be considered as a diagnostic clue.3,4

There are a variety of orthopedic manifestations of NPS. Hypoplastic or absent patellae leading to recurrent subluxations or dislocations is a common finding.4 Bilateral symmetric bone formations (horns) arising from the iliac crest are pathognomonic but only found on radiography 70% of the time.6 Occasionally these protuberances can be palpated on physical examination,5 though this finding was not appreciated in our patient. Dysplasia of the elbows may result in limited elbow extension and limited pronation and supination. Early degenerative arthritis, lumbar lordosis, and scoliosis also are not uncommon. In addition, skeletal integrity is compromised, leading to early osteoporosis and increased risk for fractures.5

Nephropathy develops in approximately 30% to 40% of patients and is a major determinant of mortality in these patients.2 Mutations in the LMX1B gene lead to abnormal development of podocytes and reduction in collagen in the glomerular basement membrane. The first sign of renal involvement usually is proteinuria, with or without microscopic hematuria. As in our patient, many patients develop hypertension. Patients may progress to develop nephrotic syndrome and end-stage renal failure (5%–10%).7 Death from NPS-related nephropathy has occurred, even in childhood.4,5

Primary open-angle glaucoma has been recognized as a feature of NPS.8 It is the most frequent ocular abnormality observed, followed by ocular hypertension and Lester sign of the iris.3,5 These conditions also are more common in younger patients with NPS than in the general population.5 Important neurologic findings include epilepsy, peripheral neuropathy, attention deficit disorder, major depressive disorder, and vasomotor problems.9

Our case highlights the importance of recognizing this rare condition to provide a multidisciplinary approach to care that addresses all aspects of LMX1B-associated disease in affected individuals. Nail findings may be the first clue to the need for additional screenings in these patients. Nail-patella syndrome patients should undergo thorough ophthalmologic examinations every 2 years, including measurement of intraocular pressure, examination of the optic disc, and assessment of visual fields. Given the variability in severity of joint problems and the unpredictable anatomy of the joints, magnetic resonance imaging of the joints is recommended prior to orthopedic intervention. Most importantly, physicians should recognize this genodermatosis to implement periodic screenings for renal disease, as up to 40% of NPS patients develop kidney failure. Annual blood pressure measurements, urinalysis, and measurement of the protein to creatinine ratio in the urine are recommended. For patients with end-stage renal failure, renal transplantation results in cure of nephropathy and may even result in nail regrowth.10 Further, this case is notable in that it describes a patient with NPS who is older than most other individuals presenting with the condition, thereby revealing novel information about NPS in its more advanced stages.

Nail-patella syndrome (NPS), also known as hereditary osteo-onychodysplasia syndrome, is a rare autosomal-dominant disorder with an estimated incidence of 1 per 50,000 individuals in the United States. Nail-patella syndrome presents due to a heterozygous loss-of-function mutation in the LIM homeobox transcription factor 1 beta gene, LMX1B, on chromosome 9q34.1 LMX1B gene mutations are fully penetrant, but there is variable expressivity, even within families.2

Case Report

A 69-year-old man presented to the dermatology clinic for a routine skin cancer screening. The patient’s history was remarkable for dystrophic fingernails and toenails since birth. In his 20s he developed progressively worsening instability of the left knee and chronic back pain due to scoliosis, lumbar lordosis, and spinal disc herniation. Since then, he underwent knee surgery and 7 back surgeries for rheumatologic disease. His medical history also was remarkable for osteoporosis, hypertension, and glaucoma. Family history was notable for similar findings in the patient’s sister; mother; and maternal aunt, uncle, and grandmother, all with varying disease severity.

Physical examination was remarkable for bilateral fingernail hypoplasia that was most prominent on the thumb, with improvement in each nail on progression toward the fifth digit (Figure 1A). Triangular fingernail lunulae, longitudinal ridging, and nail splitting were present (Figure 1A and 1B). Hypoplastic crumbly toenails also were appreciated (Figure 1C). Skin creases over the distal interphalangeal joints of the fingers and toes were conspicuously absent. Limited range of motion was noted in multiple joints, with profound limitation of bilateral elbow extension. Review of prior imaging reports revealed bilateral iliac horns as well as left patellar absence and right patellar hypoplasia (Figure 2). Urinalysis was remarkable for proteinuria and microscopic hematuria. Given the constellation of examination findings and positive family history, a diagnosis of NPS was made.

Figure 1. Nail-patella syndrome characterized by thumbnail hypoplasia (A) as well as triangular lunulae and longitudinal ridging with nail splitting (B). Hypoplastic crumbly toenails were appreciated (C).

Figure 2. Lateral radiographs of the knee joints demonstrated right patellar hypoplasia (A) and left patellar absence (B). A radiograph of the pelvis revealed bilateral triangular osseous excrescences from the posterior ilia, known as iliac horns (arrow)(C). Metallic orthopedic hardware from multiple spinal surgeries performed on the patient also can be appreciated, presumably long-term sequelae of the patient’s condition.

Comment

Nail-patella syndrome is characterized by variable dermatologic, neurologic, nephrogenic, ophthalmologic, and orthopedic clinical manifestations.3 Almost all patients with NPS have bilateral and symmetric nail changes, including absent or hypoplastic nails with ridging, splitting, or discoloration and triangular-shaped lunulae.1,4 Nail findings are the most consistent findings of NPS, as they are present in more than 98% of patients.5 The thumb often is the most severely affected nail, with improvement appreciated on progression toward the fifth digit, as seen in our patient (Figure 1A).5 Each individual nail usually is more severely affected on its ulnar side. When toenails are involved, the abnormalities tend to be less severe, and the little toenail is most commonly affected. Distal digital changes also are observed in almost all patients. Loss of dorsal creases in the skin overlying the distal interphalangeal joints can be considered as a diagnostic clue.3,4

There are a variety of orthopedic manifestations of NPS. Hypoplastic or absent patellae leading to recurrent subluxations or dislocations is a common finding.4 Bilateral symmetric bone formations (horns) arising from the iliac crest are pathognomonic but only found on radiography 70% of the time.6 Occasionally these protuberances can be palpated on physical examination,5 though this finding was not appreciated in our patient. Dysplasia of the elbows may result in limited elbow extension and limited pronation and supination. Early degenerative arthritis, lumbar lordosis, and scoliosis also are not uncommon. In addition, skeletal integrity is compromised, leading to early osteoporosis and increased risk for fractures.5

Nephropathy develops in approximately 30% to 40% of patients and is a major determinant of mortality in these patients.2 Mutations in the LMX1B gene lead to abnormal development of podocytes and reduction in collagen in the glomerular basement membrane. The first sign of renal involvement usually is proteinuria, with or without microscopic hematuria. As in our patient, many patients develop hypertension. Patients may progress to develop nephrotic syndrome and end-stage renal failure (5%–10%).7 Death from NPS-related nephropathy has occurred, even in childhood.4,5

Primary open-angle glaucoma has been recognized as a feature of NPS.8 It is the most frequent ocular abnormality observed, followed by ocular hypertension and Lester sign of the iris.3,5 These conditions also are more common in younger patients with NPS than in the general population.5 Important neurologic findings include epilepsy, peripheral neuropathy, attention deficit disorder, major depressive disorder, and vasomotor problems.9

Our case highlights the importance of recognizing this rare condition to provide a multidisciplinary approach to care that addresses all aspects of LMX1B-associated disease in affected individuals. Nail findings may be the first clue to the need for additional screenings in these patients. Nail-patella syndrome patients should undergo thorough ophthalmologic examinations every 2 years, including measurement of intraocular pressure, examination of the optic disc, and assessment of visual fields. Given the variability in severity of joint problems and the unpredictable anatomy of the joints, magnetic resonance imaging of the joints is recommended prior to orthopedic intervention. Most importantly, physicians should recognize this genodermatosis to implement periodic screenings for renal disease, as up to 40% of NPS patients develop kidney failure. Annual blood pressure measurements, urinalysis, and measurement of the protein to creatinine ratio in the urine are recommended. For patients with end-stage renal failure, renal transplantation results in cure of nephropathy and may even result in nail regrowth.10 Further, this case is notable in that it describes a patient with NPS who is older than most other individuals presenting with the condition, thereby revealing novel information about NPS in its more advanced stages.

References
  1. Harita Y, Kitanaka S, Isojima T, et al. Spectrum of LMX1B mutations: from nail-patella syndrome to isolated nephropathy [published online July 23, 2016]. Pediatr Nephrol. doi:10.1007/s00467-016-3462-x.
  2. Ghoumid J, Petit F, Holder-Espinasse M, et al. Nail-patella syndrome: clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity [published online April 22, 2015]. Eur J Hum Genet. 2016;24:44-50.
  3. Tong SY, Luk HM, Tong TM, et al. The nail points to the diagnosis. Fong disease or hereditary osteo-onychodysplasia. Hong Kong Med J. 2015;21:573.e3-573.e5.
  4. Figueroa-Silva O, Vicente A, Agudo A, et al. Nail-patella syndrome: report of 11 pediatric cases. J Eur Acad Dermatol Venereol. 2016;30:1614-1617.
  5. Sweeney E, Fryer A, Mountford R, et al. Nail patella syndrome: a review of the phenotype aided by developmental biology. J Med Genet. 2003;40:153-162.
  6. Tigchelaar S, Lenting A, Bongers EM, et al. Nail patella syndrome: knee symptoms and surgical outcomes. a questionnaire-based survey [published online November 17, 2015]. Orthop Traumatol Surg Res. 2015;101:959-962.
  7. Lemley KV. Kidney disease in nail-patella syndrome [published online June 6, 2008]. Pediatr Nephrol. 2009;24:2345-2354.
  8. Sweeney E, Hoover-Fong JE, McIntosh I. Nail-patella syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews. Seattle, WA: University of Washington, Seattle; 2003. https://www.ncbi.nlm.nih.gov/books/NBK1132/. Updated November 13, 2014. Accessed January 30, 2018.
  9. Lopez-Arvizu C, Sparrow EP, Strube MJ, et al. Increased symptoms of attention deficit hyperactivity disorder and major depressive disorder symptoms in nail-patella syndrome: potential association with LMX1B loss-of-function [published online November 2, 2010]. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:59-66.
  10. Chan PC, Chan KW, Cheng IK, et al. Living-related renal transplantation in a patient with nail-patella syndrome. Nephron. 1988;50:164-166.
References
  1. Harita Y, Kitanaka S, Isojima T, et al. Spectrum of LMX1B mutations: from nail-patella syndrome to isolated nephropathy [published online July 23, 2016]. Pediatr Nephrol. doi:10.1007/s00467-016-3462-x.
  2. Ghoumid J, Petit F, Holder-Espinasse M, et al. Nail-patella syndrome: clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity [published online April 22, 2015]. Eur J Hum Genet. 2016;24:44-50.
  3. Tong SY, Luk HM, Tong TM, et al. The nail points to the diagnosis. Fong disease or hereditary osteo-onychodysplasia. Hong Kong Med J. 2015;21:573.e3-573.e5.
  4. Figueroa-Silva O, Vicente A, Agudo A, et al. Nail-patella syndrome: report of 11 pediatric cases. J Eur Acad Dermatol Venereol. 2016;30:1614-1617.
  5. Sweeney E, Fryer A, Mountford R, et al. Nail patella syndrome: a review of the phenotype aided by developmental biology. J Med Genet. 2003;40:153-162.
  6. Tigchelaar S, Lenting A, Bongers EM, et al. Nail patella syndrome: knee symptoms and surgical outcomes. a questionnaire-based survey [published online November 17, 2015]. Orthop Traumatol Surg Res. 2015;101:959-962.
  7. Lemley KV. Kidney disease in nail-patella syndrome [published online June 6, 2008]. Pediatr Nephrol. 2009;24:2345-2354.
  8. Sweeney E, Hoover-Fong JE, McIntosh I. Nail-patella syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews. Seattle, WA: University of Washington, Seattle; 2003. https://www.ncbi.nlm.nih.gov/books/NBK1132/. Updated November 13, 2014. Accessed January 30, 2018.
  9. Lopez-Arvizu C, Sparrow EP, Strube MJ, et al. Increased symptoms of attention deficit hyperactivity disorder and major depressive disorder symptoms in nail-patella syndrome: potential association with LMX1B loss-of-function [published online November 2, 2010]. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:59-66.
  10. Chan PC, Chan KW, Cheng IK, et al. Living-related renal transplantation in a patient with nail-patella syndrome. Nephron. 1988;50:164-166.
Issue
Cutis - 101(2)
Issue
Cutis - 101(2)
Page Number
126-129
Page Number
126-129
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Hair & Nails
Article Type
Article
Display Headline
Nail-Patella Syndrome: Clinical Clues for Making the Diagnosis
Display Headline
Nail-Patella Syndrome: Clinical Clues for Making the Diagnosis
Sections
Case Reports
Inside the Article

Practice Points

  • Nail-patella syndrome (NPS) is a multisystem disease.
  • Nail findings (eg, triangular lunulae) may be the first clue to NPS and should prompt investigation of associated renal, ocular, neurologic, skeletal, and orthopedic abnormalities.
  • Early intervention and a multidisciplinary approach to care can improve morbidity and mortality in patients with NPS.
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Teaser Media
Article PDF Media